Medicine and Dentistry
Pulmonary Hypertension
100%
Obstructive Sleep Apnea
29%
Dyspnea
25%
Disease
24%
Treprostinil
23%
Exercise
23%
Idiopathic Pulmonary Fibrosis
22%
Enteric Feeding
21%
Stress Ulcer
21%
Stroke Volume
21%
Tertiary Care
21%
Pulmonary Artery
19%
Comorbidity
18%
Apnea
18%
Intensive Care Unit
17%
Hemodynamic
17%
Hypopnea
16%
Down Syndrome
16%
Vasodilator Agent
16%
Gasping
15%
Echocardiography
15%
Case Presentation
14%
Gastrointestinal Bleeding
13%
Adenotonsillectomy
13%
Atrial Septal Defect
13%
Sleep-Disordered Breathing in Children
12%
Post-Hoc Analysis
12%
Mental Health
11%
Cardiovascular System
11%
Interstitial Lung Disease
11%
Epileptic Seizure
10%
Central Sleep Apnea
10%
Intractable Epilepsy
10%
Ischemic Mitral Valve Regurgitation
10%
Human Immunodeficiency Virus
10%
Asthma
10%
Clinician
10%
Drug Resistant Epilepsy
10%
Heart Amyloidosis
10%
Quality Improvement
10%
G Protein Coupled Receptor
10%
Cohort Analysis
10%
Virus Infection
10%
Bleeding
10%
Therapy Delay
10%
Bronchodilating Agent
10%
Rosai-Dorfman Disease
10%
Infectious Complication
10%
Chronic Obstructive Pulmonary Disease
10%
Adenoid Hypertrophy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
89%
Treprostinil
42%
Stress Ulcer
21%
Disease
21%
Sleep Disordered Breathing
21%
Clinical Study
20%
Gastrointestinal Hemorrhage
17%
Apnea
17%
Interstitial Lung Disease
11%
Tolerability
11%
Placebo
10%
Lung Embolism
10%
Mediastinitis
10%
HIV
10%
Inflammation
10%
Cardiovascular Disease
10%
Hypertension
10%
Peripheral Occlusive Artery Disease
10%
G Protein Coupled Receptor
10%
Heart Atrium Septum Defect
10%
Proton Pump Inhibitor
10%
Proadrenomedullin
10%
Down Syndrome
10%
Heart Failure
10%
Case-Control Study
10%
Comorbidity
10%
Clinical Trial
9%
Heavy Metal
7%
Prevalence
7%
Human Immunodeficiency Virus Infection
7%
Atherosclerosis
7%
Disease Exacerbation
7%
Retrospective Study
7%
Combination Therapy
6%
Lung Disease
6%
Brain Natriuretic Peptide
5%
Adverse Event
5%
Ion Channel
5%
Obstruction
5%
Pantoprazole
5%
Coronary Artery Disease
5%
Heart Ventricle Remodeling
5%
Pathophysiology
5%
Syndrome
5%
Thorax Pain
5%
Heart Infarction
5%
Rectum Carcinoma
5%
Vascular Remodeling
5%
Epileptic Absence
5%
Keyphrases
Environmental Metals
21%
Inhaled Treprostinil
18%
Pulmonary Hypertension
15%
Bridge-to-surgery
10%
Fibroblasts
10%
Acute Ischemic Mitral Regurgitation
10%
Enteral nutrition
10%
Bleeding
10%
Event Distribution
10%
Upper Gastrointestinal Tract
10%
Pseudoaneurysm
10%
Interstitial Lung Disease
10%
Closed Model
10%
Treatment Delay
10%
Pulmonary Hypertension Treatment
10%
Oropharyngeal
10%
Fibrosing Mediastinitis
10%
Defect Management
10%
Necrobiotic
10%
Adenoid Hypertrophy
10%
Tyvaso
10%
Inhalable Dry Powder
10%
Extraintestinal Manifestations
10%
Cryptococcus
10%
Fibroblast Heterogeneity
10%
Typical Carcinoid
10%
Case-cohort Study
10%
International Case
10%
Redox Homeostasis
10%
Molar Tooth Sign
10%
Vici Syndrome
10%
Real-world Treatment Patterns
10%
G Protein-coupled Receptor
10%
Vasodilator
10%
Antimony
10%
Associated Diseases
10%
Peritonitis
10%
Massive Pulmonary Embolism
10%
Hoarseness of Voice
10%
Cardiovascular Effects
10%
Resident Continuity Clinic
10%
Proton Pump Inhibitors
10%
MR-proADM
10%
Smoking-related Interstitial Fibrosis
10%
Krukenberg Tumor
10%
Carotid Flow Time
10%
Pulmonary Artery
10%
Fraction Volume
10%
Hypertension Comorbidities
10%
Wood
8%
